Financial statements Inpharm
Balance sheet data of INPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|
| Total assets | 218 338,11 | 187 682,97 | 228 894,54 | 212 190,06 | 193 997,45 | 1 031 066,07 | 1 218 063,92 |
| A. Fixed assets | 2 125,00 | 1 624,99 | 1 125,00 | 624,99 | 124,99 | 17 633,00 | 45 194,40 |
| B. Current assets | 216 213,11 | 186 057,98 | 227 769,54 | 211 565,07 | 193 872,46 | 1 013 433,07 | 1 172 869,52 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - | - | 0,00 | 0,00 |
| Total liabilities | 218 338,11 | 187 682,97 | 228 894,54 | 212 190,06 | 193 997,45 | 1 031 066,07 | 1 218 063,92 |
| A. Equity | -5 118,66 | -67 483,14 | -147 081,19 | -211 035,83 | -210 987,13 | -260 344,81 | -987 292,87 |
| B. Liabilities and provisions for liabilities | 223 456,77 | 255 166,11 | 375 975,73 | 423 225,89 | 404 984,58 | 1 291 410,88 | 2 205 356,79 |
| I. Long-term liabilities | 0,00 | 0,00 | 17 000,00 | - | - | - | 1 397 674,80 |
| II. Short-term liabilities | 223 456,77 | 255 166,11 | 358 975,73 | - | - | - | 787 863,39 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD